AbbVie (ABBV) Total Debt (2012 - 2026)

AbbVie (ABBV) has reported Total Debt for 15 consecutive years, with $70.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Debt fell 4.39% year-over-year to $70.8 billion in Q2 2026; TTM through Jun 2026 was $70.8 billion, a 4.39% decrease from a year earlier, with the FY2025 full-year figure at $67.5 billion, up 0.52% from the prior year.
• Total Debt was $70.8 billion for Q2 2026 at AbbVie, down from $72.9 billion in the prior quarter.
• Over five years, Total Debt peaked at $74.1 billion in Q2 2025 and troughed at $59.4 billion in Q4 2023.
• A 5-year average of $68.4 billion and a median of $70.2 billion in 2025 frame the typical range for Total Debt.
• Across the five-year window, Total Debt fell 17.49% in 2022 and rose 19.18% in 2024, its largest moves.
• Over 5 years, Total Debt stood at $63.3 billion in 2022, then slipped by 6.14% to $59.4 billion in 2023, then rose by 13.07% to $67.1 billion in 2024, then climbed by 0.52% to $67.5 billion in 2025, then grew by 4.93% to $70.8 billion in 2026.
• The last three Total Debt figures came in at $70.8 billion (Q2 2026), $72.9 billion (Q1 2026), and $67.5 billion (Q4 2025), per Business Quant data.